CDC42 and breast carcinoma: To assess the potential significance of ACTR2 and CDC42 expressions in breast cancer, we generated Kaplan–Meier survival plots for relapse-free survival (RFS) and distant metastasis-free survival (DMFS) using available gene expression dataset records, spanning a period of up to 180 months.